High Content & Phenotypic Screening 2017 Workshop

Please Register for this Event using this Link.

Join high-content imaging experts as they discuss their experiences with high-content screening and 3D imaging, sharing findings and best practice. 

The user meeting will begin with a presentation from Ute Jungwirth, Institute of Cancer Research, London, about the development and characterisation of novel isogeneic, spontaneous breast cancer metastasis models. The cell lines, which were characterised using high-content 2D and 3D imaging, could provide important independent syngeneic models for investigating the molecular and cellular mechanisms underpinning metastatic breast cancer progression.

An overview of various imaging applications, such as 3D-spheroid imaging, slide scanning, protein co-localization assays, fast kinetic processes like beating cardiomyocytes, and zebrafish imaging, will then be discussed by an Application Scientist from Molecular Devices. 

To end this exciting meeting, we have a presentation from Nathalie Maubon and Grégory Maubon, HCS Pharma, Rennes, about the use of 3D cultures in phenotypic screening with examples from oncology, CNS and metabolic diseases. They will also discuss the changing perceptions and processes that are needed to take HCS to the next level, with cutting-edge technologies such as virtual and augmented realities, deep learning and machine learning.

18:00   Opening Words
18:05   Development and Characterisation of a Novel Isogeneic, Spontaneous Breast Cancer Metastasis Model -  Ute Jungwirth, Institute of Cancer Research, London, UK 
18:35   Recent and Novel ImageXpress 3D Confocal and Widefield Applications - Sarah Rowe, Application Scientist, Molecular Devices 
18:55  3D Culture in Phenotypic Screening: Advantages, Process Changes and New Tech6nologies Needed  -Nathalie Maubon and Grégory Maubon,  HCS Pharma, Rennes, France 
19:20 Closing Words 
19:30 Open Discussion with Buffet Supper



We hope you will join us for this unique HCS educational and networking event.

You Will Learn About:
• The development of a new cell model for investigating metastatic breast cancer progression
• Insights into acquiring and analyzing data for a variety of high-throughput 3D and live-cell imaging applications
• The use of 3D cultures in phenotypic screening
• Cutting-edge HCS technologies such as virtual and augmented realities, deep learning and machine learning

Who Should Attend:
• Researchers interested in cutting-edge HCS technologies
• HCS scientists working with different samples in multi-user environments
• Researchers interested in metastatic cancer progression
• Academic and pharma scientists working on cell line development and characterisation
• Researchers interested in the phenotypic and high-content screening of 3D models